Comment on 'Pityriasis rubra pilaris-like eruption following mRNA COVID-19 vaccine'

被引：1
作者：
Potestio, Luca [1 ]
Genco, Lucia [1 ]
Noto, Matteo [1 ]
Fabbrocini, Gabriella [1 ]
Battista, Teresa [1 ]
Martora, Fabrizio [1 ]
机构：
[1] Univ Naples Federico II, Dept Clin Med & Surg, Sect Dermatol, Naples, Italy
来源：
CLINICAL AND EXPERIMENTAL DERMATOLOGY | 2023年 / 48卷 / 01期
关键词：
D O I：
10.1093/ced/llac012
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
[No abstract available]
引用
收藏
页码：44 / 45
页数：2
相关论文
共 11 条
[1]   Pityriasis rubra pilaris (type I) following ChAdOx1 COVID-19 vaccine: A report of two cases with successful treatment with oral isotretinoin [J].
Criado, P. R. ;
Ianhez, M. ;
Rocha, P. S. ;
Miot, H. A. .
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2022, 36 (07) :E508-E510
[2]   Pityriasis rubra pilaris following booster dose of mRNA (Pfizer-BioNTech) COVID-19 vaccine [J].
Hlaca, Nika ;
Zagar, Tina ;
Kastelan, Marija ;
Peternel, Sandra ;
Brajac, Ines ;
Dujmovic-Hasanbegovic, Katarina ;
Prpic-Massari, Larisa .
DERMATOLOGIC THERAPY, 2022, 35 (11)
[3]   Pityriasis rubra pilaris-like eruption following administration of the BNT163b2 (Pfizer-BioNTech) mRNA COVID-19 vaccine [J].
Hunjan, M. K. ;
Roberts, C. ;
Karim, S. ;
Hague, J. .
CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2022, 47 (01) :188-190
[4]   Skin reaction after SARS-CoV-2 vaccines Reply to 'cutaneous adverse reactions following SARS-CoV-2 vaccine booster dose: A real-life multicentre experience' [J].
Martora, Fabrizio ;
Villani, Alessia ;
Marasca, Claudio ;
Fabbrocini, Gabriella ;
Potestio, Luca .
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2023, 37 (01) :E43-E44
[5]   Teledermatology: A useful tool also after COVID-19 era? [J].
Megna, Matteo ;
Camela, Elisa ;
Villani, Alessia ;
Tajani, Andrea ;
Fabbrocini, Gabriella ;
Potestio, Luca .
JOURNAL OF COSMETIC DERMATOLOGY, 2022, 21 (06) :2309-2310
[6]   Shaping the future of teledermatology: a literature review of patient and provider satisfaction with synchronous teledermatology during the COVID-19 pandemic [J].
Miller, John ;
Jones, Elizabeth .
CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2022, 47 (11) :1903-1909
[7]   Comment on: 'Pityriasis rubra pilaris-like eruption following mRNA COVID-19 vaccine' [J].
Mungmunpuntipantip, Rujittika ;
Wiwanitkit, Viroj .
CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2022, 47 (06) :1195-1196
[8]   Reply to 'Cutaneous adverse effects of the available COVID-19 vaccines in India: A questionnaire-based study'. by Bawane J et al [J].
Potestio, L. ;
Genco, L. ;
Villani, A. ;
Marasca, C. ;
Fabbrocini, G. ;
Fornaro, L. ;
Ruggiero, A. ;
Martora, F. .
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2022, 36 (11) :E863-E864
[9]   Cutaneous reactions following booster dose of COVID-19 mRNA vaccination: What we should know? [J].
Potestio, Luca ;
Villani, Alessia ;
Fabbrocini, Gabriella ;
Martora, Fabrizio .
JOURNAL OF COSMETIC DERMATOLOGY, 2022, 21 (11) :5339-5340
[10]   Video and telephone teledermatology consultations during COVID-19 in comparison: patient satisfaction, doubts and concerns [J].
Ruggiero, Angelo ;
Megna, Matteo ;
Fabbrocini, Gabriella ;
Martora, Fabrizio .
CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2022, 47 (10) :1863-1864
12